Nènè Oumou Kesso Barry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nènè Oumou Kesso Barry has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- El Hadji Malick Ndour
Pharmaceutical Biochemistry Laboratory, Faculty of Medicine, Pharmacy, Cheikh Anta Diop University, Dakar, Senegal
5 shared publications - Pascal Reynier
Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France
4 shared publications - Djite Moustapha
Pharmaceutical Biochemistry Laboratory, Faculty of Medicine, Pharmacy, Cheikh Anta Diop University, Dakar, Senegal; Biochemistry-Hematology Laboratory, Fann University Hospital, Dakar, Senegal
3 shared publications - Fatou Gueye Tall
Pharmaceutical Biochemistry Laboratory, Faculty of Medicine, Pharmacy, Cheikh Anta Diop University, Dakar, Senegal
3 shared publications - Gueye Papa Madieye
Pharmaceutical Biochemistry Laboratory, Faculty of Medicine, Pharmacy, Cheikh Anta Diop University, Dakar, Senegal; Biochemistry-Hematology Laboratory, Fann University Hospital, Dakar, Senegal
3 shared publications - Kandji Pape Matar
Pharmaceutical Biochemistry Laboratory, Cheikh Anta Diop University, Dakar, Senegal; Biochemistry-Hematology Laboratory, Fann University Hospital, Dakar, Senegal
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Scientific Reports
Metabolomic rewiring of energy, structural and signaling networks underlies triple negative breast cancer aggressiveness
- 10 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessMetabolomic rewiring of energy, structural and signaling networks underlies triple negative breast cancer aggressiveness
- Open Access
- 6 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 494
Systemic Inflammatory and Hematological Profiles in Triple-Negative Breast Cancer: A Study from a Senegalese Cohort
Background/Objectives: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with a poor prognosis and limited treatment options. Inflammatory and hematological biomarkers have emerged as potential tools for disease characterization, particularly in low-resource settings. Methods: This cross-sectional analytical study was conducted between July 2022 and February 2024 at Dalal Jamm Hospital in Dakar, Senegal, and included 120 women: 40 with TNBC, 40 with hormone-dependent breast cancer (HDBC), and 40 healthy controls. Blood samples were collected at diagnosis before any treatment to measure complete blood counts and C-reactive protein (CRP) levels. Inflammatory ratios—neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR)—were calculated. Results: TNBC patients displayed a distinct inflammatory profile characterized by elevated neutrophil counts, CRP, NLR, and MLR, as well as reduced lymphocyte and basophil percentages compared to healthy controls. NLR > 1.12 demonstrated strong discriminatory ability (AUC = 0.847; sensitivity 90%; specificity 65%). Differences between TNBC and HDBC were less pronounced, except for CRP and basophil levels. Multivariate analysis confirmed independent associations of elevated NLR, CRP, and neutrophils with TNBC. Conclusions: These findings provide new insights into the inflammatory and hematological characteristics of TNBC in this population and support further investigation of accessible biomarkers for early disease stratification in similar settings.
- 6 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 494
Open AccessSystemic Inflammatory and Hematological Profiles in Triple-Negative Breast Cancer: A Study from a Senegalese Cohort
Background/Objectives: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with a poor prognosis and limited treatment options. Inflammatory and hematological biomarkers have emerged as potential tools for disease characterization, particularly in low-resource settings. Methods: This cross-sectional analytical study was conducted between July 2022 and February 2024 at Dalal Jamm Hospital in Dakar, Senegal, and included 120 women: 40 with TNBC, 40 with hormone-dependent breast cancer (HDBC), and 40 healthy controls. Blood samples were collected at diagnosis before any treatment to measure complete blood counts and C-reactive protein (CRP) levels. Inflammatory ratios—neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR)—were calculated. Results: TNBC patients displayed a distinct inflammatory profile characterized by elevated neutrophil counts, CRP, NLR, and MLR, as well as reduced lymphocyte and basophil percentages compared to healthy controls. NLR > 1.12 demonstrated strong discriminatory ability (AUC = 0.847; sensitivity 90%; specificity 65%). Differences between TNBC and HDBC were less pronounced, except for CRP and basophil levels. Multivariate analysis confirmed independent associations of elevated NLR, CRP, and neutrophils with TNBC. Conclusions: These findings provide new insights into the inflammatory and hematological characteristics of TNBC in this population and support further investigation of accessible biomarkers for early disease stratification in similar settings.
- Open Access
- 19 April 2025
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 13 (1) , 1-6
Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital
Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management.
- 19 April 2025
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 13 (1) , 1-6
Open AccessCorrelation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital
Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management.
- Open Access
- 18 October 2024
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 12 (4) , 143-148
Evaluation of the Determinants of Microalbuminuria in Type 2 Diabetic Subjects
Diabetes is a metabolic disease characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or insulin action. When not well controlled, it leads to long-term microangiopathic complications, including diabetic nephropathy. Against this backdrop, we set out to evaluate microalbuminuria and the clinical and biological factors associated with it in subjects with type 2 diabetes. This is a prospective, descriptive study including type 2 diabetic patients well followed at the Mark Sankale Center of the Abass Ndao Hospital in Dakar. Biochemical parameters (microalbuminuria, lipid profile, glycated hemoglobin and fasting blood glucose) were measured using enzymatic techniques with the Cobas 6000/c501® system (Roche, Hitachi, Germany). XLSTAT software was used to evaluate the data, and a value of p<0.05 was considered a statistically significant difference. A total of 166 diabetic patients with a mean age of 54 ±13.9 years and a sex ratio of 0.50 were included in our study. Microalbuminuria was present in 40.36% of the study population. Among patients with unbalanced diabetes, 50.74% had positive microalbuminuria. When hypertension was associated with diabetes, microalbuminuria was positive in 61.19% of patients. In terms of dyslipidemia, hypercholesterolemia was the only abnormality significantly associated with microalbuminuria (p<0.001). Microalbuminuria is an essential parameter in the detection of diabetic nephropathy. In our study, its occurrence was associated with several abnormalities, including unbalanced diabetes, hypertension and hypercholesterolemia.
- 18 October 2024
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 12 (4) , 143-148
Open AccessEvaluation of the Determinants of Microalbuminuria in Type 2 Diabetic Subjects
Diabetes is a metabolic disease characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or insulin action. When not well controlled, it leads to long-term microangiopathic complications, including diabetic nephropathy. Against this backdrop, we set out to evaluate microalbuminuria and the clinical and biological factors associated with it in subjects with type 2 diabetes. This is a prospective, descriptive study including type 2 diabetic patients well followed at the Mark Sankale Center of the Abass Ndao Hospital in Dakar. Biochemical parameters (microalbuminuria, lipid profile, glycated hemoglobin and fasting blood glucose) were measured using enzymatic techniques with the Cobas 6000/c501® system (Roche, Hitachi, Germany). XLSTAT software was used to evaluate the data, and a value of p<0.05 was considered a statistically significant difference. A total of 166 diabetic patients with a mean age of 54 ±13.9 years and a sex ratio of 0.50 were included in our study. Microalbuminuria was present in 40.36% of the study population. Among patients with unbalanced diabetes, 50.74% had positive microalbuminuria. When hypertension was associated with diabetes, microalbuminuria was positive in 61.19% of patients. In terms of dyslipidemia, hypercholesterolemia was the only abnormality significantly associated with microalbuminuria (p<0.001). Microalbuminuria is an essential parameter in the detection of diabetic nephropathy. In our study, its occurrence was associated with several abnormalities, including unbalanced diabetes, hypertension and hypercholesterolemia.
- Open Access
- 12 April 2024
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 12 (2) , 76-84
Performances of Proteinuria as Compared with Albuminuria in Screening for Microalbuminuria During Sickle Cell Anaemia
Albuminuria is the gold standard for the screening of microalbuminuria, a biomarker of early onset of nephropathy during sickle cell anemia (SCA). Nephropathy increase morbidity and mortality of SCA in the absence of appropriate treatment. However, albuminuria is not readily available or affordable in resource-limited countries, so in 2012 Kidney Diseases Improving Global Outcomes (KDIGO) proposed using proteinuria at a threshold of 150 mg/g urine creatinine to screen for microalbuminuria in these settings. The aim of this study was therefore to assess the performance of proteinuria in screening microalbuminuria in sub-Saharan Senegalese sickle cell patients. Albuminuria in recruited SS sickle cell patients was expressed as a urine albumin-to-creatinine ratio (UACR) and proteinuria as a urine proteins-to-creatinine ratio (UPCR). The prevalence of microalbuminuria, Cohen's kappa coefficient and areas under the curve (AUC) were then determined to assess the performance of proteinuria in detecting microalbuminuria. A total of 150 patients with a median age of 20 years [minimum-maximum: 4-57] and a female proportion of 51.33% were included in the study. Microalbuminuria was present in 42.38% (n=64) of subjects according to the UPCR. The Cohen's kappa coefficient was 0.41 [IC95%: 0.27-0.56] and the AUC 0.71 [IC95%: 0.64 - 0.81] with UPCR 150mg/g. The best Cohen's kappa coefficient and AUC were observed with an UPCR threshold of 135 mg/g. Our results confirm that proteinuria is useful in screening for microalbuminuria and show that RPCU 135 mg/g would be the optimal cut-off for detecting microalbuminuria in Senegalese sickle cell anemia patients.
- 12 April 2024
- Published by Science Publishing Group in Advances in Biochemistry
- Vol. 12 (2) , 76-84
Open AccessPerformances of Proteinuria as Compared with Albuminuria in Screening for Microalbuminuria During Sickle Cell Anaemia
Albuminuria is the gold standard for the screening of microalbuminuria, a biomarker of early onset of nephropathy during sickle cell anemia (SCA). Nephropathy increase morbidity and mortality of SCA in the absence of appropriate treatment. However, albuminuria is not readily available or affordable in resource-limited countries, so in 2012 Kidney Diseases Improving Global Outcomes (KDIGO) proposed using proteinuria at a threshold of 150 mg/g urine creatinine to screen for microalbuminuria in these settings. The aim of this study was therefore to assess the performance of proteinuria in screening microalbuminuria in sub-Saharan Senegalese sickle cell patients. Albuminuria in recruited SS sickle cell patients was expressed as a urine albumin-to-creatinine ratio (UACR) and proteinuria as a urine proteins-to-creatinine ratio (UPCR). The prevalence of microalbuminuria, Cohen's kappa coefficient and areas under the curve (AUC) were then determined to assess the performance of proteinuria in detecting microalbuminuria. A total of 150 patients with a median age of 20 years [minimum-maximum: 4-57] and a female proportion of 51.33% were included in the study. Microalbuminuria was present in 42.38% (n=64) of subjects according to the UPCR. The Cohen's kappa coefficient was 0.41 [IC95%: 0.27-0.56] and the AUC 0.71 [IC95%: 0.64 - 0.81] with UPCR 150mg/g. The best Cohen's kappa coefficient and AUC were observed with an UPCR threshold of 135 mg/g. Our results confirm that proteinuria is useful in screening for microalbuminuria and show that RPCU 135 mg/g would be the optimal cut-off for detecting microalbuminuria in Senegalese sickle cell anemia patients.
- Open Access
- 29 December 2023
- Published by MDPI AG in Antioxidants
- Vol. 13 (1) , 60
A Metabolomic Signature of Ischemic Stroke Showing Acute Oxidative and Energetic Stress
Metabolomics is a powerful data-driven tool for in-depth biological phenotyping that could help identify the specific metabolic profile of cryptogenic strokes, for which no precise cause has been identified. We performed a targeted quantitative metabolomics study in West African patients who had recently suffered an ischemic stroke, which was either cryptogenic (n = 40) or had a clearly identified cause (n = 39), compared to a healthy control group (n = 40). Four hundred fifty-six metabolites were accurately measured. Multivariate analyses failed to reveal any metabolic profile discriminating between cryptogenic ischemic strokes and those with an identified cause but did show superimposable metabolic profiles in both groups, which were clearly distinct from those of healthy controls. The blood concentrations of 234 metabolites were significantly affected in stroke patients compared to controls after the Benjamini–Hochberg correction. Increased methionine sulfoxide and homocysteine concentrations, as well as an overall increase in saturation of fatty acids, were indicative of acute oxidative stress. This signature also showed alterations in energetic metabolism, cell membrane integrity, monocarbon metabolism, and neurotransmission, with reduced concentrations of several metabolites known to be neuroprotective. Overall, our results show that cryptogenic strokes are not pathophysiologically distinct from ischemic strokes of established origin, and that stroke leads to intense metabolic remodeling with marked oxidative and energetic stresses.
- 29 December 2023
- Published by MDPI AG in Antioxidants
- Vol. 13 (1) , 60
Open AccessA Metabolomic Signature of Ischemic Stroke Showing Acute Oxidative and Energetic Stress
Metabolomics is a powerful data-driven tool for in-depth biological phenotyping that could help identify the specific metabolic profile of cryptogenic strokes, for which no precise cause has been identified. We performed a targeted quantitative metabolomics study in West African patients who had recently suffered an ischemic stroke, which was either cryptogenic (n = 40) or had a clearly identified cause (n = 39), compared to a healthy control group (n = 40). Four hundred fifty-six metabolites were accurately measured. Multivariate analyses failed to reveal any metabolic profile discriminating between cryptogenic ischemic strokes and those with an identified cause but did show superimposable metabolic profiles in both groups, which were clearly distinct from those of healthy controls. The blood concentrations of 234 metabolites were significantly affected in stroke patients compared to controls after the Benjamini–Hochberg correction. Increased methionine sulfoxide and homocysteine concentrations, as well as an overall increase in saturation of fatty acids, were indicative of acute oxidative stress. This signature also showed alterations in energetic metabolism, cell membrane integrity, monocarbon metabolism, and neurotransmission, with reduced concentrations of several metabolites known to be neuroprotective. Overall, our results show that cryptogenic strokes are not pathophysiologically distinct from ischemic strokes of established origin, and that stroke leads to intense metabolic remodeling with marked oxidative and energetic stresses.
- Open Access
- 14 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (24) , 3664
Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case–Control Study
(1) Background: Breast cancer is the most prevalent cancer found in women in Mali. The aim of the current study was to determine the association between metabolites circulating in the blood, 25(OH)D and 1,25(OH)2D, and vitamin D levels with the risk of breast cancer in Malian women. (2) Methods: We conducted a prospective case–control study from August 2021 to March 2022. Control subjects were matched to cases according to age (within 5 years). The patients’ clinical stage was determined by the oncologist according to the tumour–nodes–metastasis (TNM) classification system. (3) Results: We observed no differences in the mean 25(OH)D (p = 0.221) and 1,25(OH)2D (p = 0.285) between cases and controls. However, our findings indicate a more pronounced inverse association in the first level of plasma 25(OH)D, while the risk function decreases at higher levels. This observation takes strength with 1,25(OH)2D by a significant association between the first quartile and breast cancer as a risk factor (p = 0.03; OR = 71.84; CI: 1.36–3785.34). (4) Conclusions: These outcomes showed a possible association between 25(OH)D and 1,25(OH)2D in decreasing the risk of breast cancer.
- 14 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (24) , 3664
Open AccessPlasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case–Control Study
(1) Background: Breast cancer is the most prevalent cancer found in women in Mali. The aim of the current study was to determine the association between metabolites circulating in the blood, 25(OH)D and 1,25(OH)2D, and vitamin D levels with the risk of breast cancer in Malian women. (2) Methods: We conducted a prospective case–control study from August 2021 to March 2022. Control subjects were matched to cases according to age (within 5 years). The patients’ clinical stage was determined by the oncologist according to the tumour–nodes–metastasis (TNM) classification system. (3) Results: We observed no differences in the mean 25(OH)D (p = 0.221) and 1,25(OH)2D (p = 0.285) between cases and controls. However, our findings indicate a more pronounced inverse association in the first level of plasma 25(OH)D, while the risk function decreases at higher levels. This observation takes strength with 1,25(OH)2D by a significant association between the first quartile and breast cancer as a risk factor (p = 0.03; OR = 71.84; CI: 1.36–3785.34). (4) Conclusions: These outcomes showed a possible association between 25(OH)D and 1,25(OH)2D in decreasing the risk of breast cancer.